Towards Targeted Delivery Systems: Ligand Conjugation Strategies for mRNA Nanoparticle Tumor Vaccines
The use of nanoparticles encapsulating messenger RNA (mRNA) as a vaccine has recently attracted much attention because of encouraging results achieved in many nonviral genetic antitumor vaccination studies. Notably, in all of these studies, mRNA nanoparticles are passively targeted to dendritic cell...
Saved in:
Main Author: | Kyle K. L. Phua |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2015/680620 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nonviral targeted mRNA delivery: principles, progresses, and challenges
by: Xi He, et al.
Published: (2025-01-01) -
mRNA vaccines as cancer therapies
by: Shaoxiong Huang, et al.
Published: (2024-12-01) -
Developing mRNA lipid nanoparticle vaccine effective for cryptococcosis in a murine model
by: Yeqi Li, et al.
Published: (2025-02-01) -
Reducing off-target expression of mRNA therapeutics and vaccines in the liver with microRNA binding sites
by: Brian J. Parrett, et al.
Published: (2025-03-01) -
The mRNA-1647 vaccine: A promising step toward the prevention of cytomegalovirus infection (CMV)
by: Adewunmi Akingbola, et al.
Published: (2025-12-01)